A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis

@inproceedings{Lee2011API,
  title={A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis},
  author={Dong Hyun Lee and Sung Yong Oh and Yu Rim Lee and Seok Jae Huh and Hyun Hwa Yoon and Sung-Hyun Kim and Suee Lee and Ji Hyun Lee and Young Hun Kim and Hyo-Jin Kim and Hyuk-Chan Kwon},
  booktitle={Cancer research and treatment : official journal of Korean Cancer Association},
  year={2011}
}
PURPOSE Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) is common and is the second most common cause of death. Clinical studies regarding chemotherapy for CRC with PC have been classically rather limited in scope. We evaluated the efficacy of modified oxaliplatin, leucovorin, and fluorouracil (m-FOLFOX4) regimen for PC of CRC origin. MATERIALS… CONTINUE READING